Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy
Clinical trial NCT01068470 · TERMINATED
Trial details
- NCT number
- NCT01068470
- Sponsor
- Loma Linda University
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.